{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T03:23:27Z","timestamp":1766805807111,"version":"3.40.3"},"publisher-location":"Singapore","reference-count":40,"publisher":"Springer Nature Singapore","isbn-type":[{"type":"print","value":"9789819901128"},{"type":"electronic","value":"9789819901135"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-981-99-0113-5_13","type":"book-chapter","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:23:23Z","timestamp":1678879403000},"page":"253-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pseudotyped Viruses for Phlebovirus"],"prefix":"10.1007","author":[{"given":"Jiajing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.virol.2021.12.010","volume":"567","author":"N Bracci","year":"2022","unstructured":"Bracci, N., et al.: Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production. Virology. 567, 65\u201376 (2022). https:\/\/doi.org\/10.1016\/j.virol.2021.12.010","journal-title":"Virology"},{"issue":"Pt 7","key":"13_CR2","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1099\/0022-1317-73-7-1745","volume":"73","author":"RM Elliott","year":"1992","unstructured":"Elliott, R.M., Dunn, E., Simons, J.F., Pettersson, R.F.: Nucleotide sequence and coding strategy of the Uukuniemi virus L RNA segment. J. Gen. Virol. 73(Pt 7), 1745\u20131752 (1992). https:\/\/doi.org\/10.1099\/0022-1317-73-7-1745","journal-title":"J. Gen. Virol."},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0168-1702(93)90076-y","volume":"27","author":"L Accardi","year":"1993","unstructured":"Accardi, L., Gro, M.C., Di Bonito, P., Giorgi, C.: Toscana virus genomic L segment: molecular cloning, coding strategy and amino acid sequence in comparison with other negative strand RNA viruses. Virus Res. 27, 119\u2013131 (1993). https:\/\/doi.org\/10.1016\/0168-1702(93)90076-y","journal-title":"Virus Res."},{"key":"13_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01713-21","volume":"96","author":"X Wang","year":"2022","unstructured":"Wang, X., et al.: Structure of Rift Valley fever virus RNA-dependent RNA polymerase. J. Virol. 96, e0171321 (2022). https:\/\/doi.org\/10.1128\/JVI.01713-21","journal-title":"J. Virol."},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0042-6822(85)90320-4","volume":"144","author":"MS Collett","year":"1985","unstructured":"Collett, M.S., et al.: Complete nucleotide sequence of the M RNA segment of Rift Valley fever virus. Virology. 144, 228\u2013245 (1985). https:\/\/doi.org\/10.1016\/0042-6822(85)90320-4","journal-title":"Virology"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0042-6822(87)90060-2","volume":"160","author":"R Ronnholm","year":"1987","unstructured":"Ronnholm, R., Pettersson, R.F.: Complete nucleotide sequence of the M RNA segment of Uukuniemi virus encoding the membrane glycoproteins G1 and G2. Virology. 160, 191\u2013202 (1987). https:\/\/doi.org\/10.1016\/0042-6822(87)90060-2","journal-title":"Virology"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12985-017-0811-8","volume":"14","author":"A Said","year":"2017","unstructured":"Said, A., Elmanzalawy, M., Ma, G., Damiani, A.M., Osterrieder, N.: An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep. Virol. J. 14, 154 (2017). https:\/\/doi.org\/10.1186\/s12985-017-0811-8","journal-title":"Virol. J."},{"key":"13_CR8","doi-asserted-by":"publisher","unstructured":"Spiegel, M., Plegge, T., Pohlmann, S.: The role of Phlebovirus glycoproteins in viral entry, assembly and release. Viruses. 8 (2016). https:\/\/doi.org\/10.3390\/v8070202","DOI":"10.3390\/v8070202"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"12200","DOI":"10.1128\/jvi.76.23.12200-12210.2002","volume":"76","author":"SR Gerrard","year":"2002","unstructured":"Gerrard, S.R., Nichol, S.T.: Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein. J. Virol. 76, 12200\u201312210 (2002). https:\/\/doi.org\/10.1128\/jvi.76.23.12200-12210.2002","journal-title":"J. Virol."},{"key":"13_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00429-21","volume":"95","author":"B Tercero","year":"2021","unstructured":"Tercero, B., Narayanan, K., Terasaki, K., Makino, S.: Characterization of the molecular interactions that govern the packaging of viral RNA segments into Rift Valley fever Phlebovirus particles. J. Virol. 95, e0042921 (2021). https:\/\/doi.org\/10.1128\/JVI.00429-21","journal-title":"J. Virol."},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1128\/JVI.58.2.263-270.1986","volume":"58","author":"K Keegan","year":"1986","unstructured":"Keegan, K., Collett, M.S.: Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus. J. Virol. 58, 263\u2013270 (1986). https:\/\/doi.org\/10.1128\/JVI.58.2.263-270.1986","journal-title":"J. Virol."},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1128\/JVI.02095-06","volume":"81","author":"BH Bird","year":"2007","unstructured":"Bird, B.H., Khristova, M.L., Rollin, P.E., Ksiazek, T.G., Nichol, S.T.: Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry. J. Virol. 81, 2805\u20132816 (2007). https:\/\/doi.org\/10.1128\/JVI.02095-06","journal-title":"J. Virol."},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrmicro3332","volume":"12","author":"RM Elliott","year":"2014","unstructured":"Elliott, R.M.: Orthobunyaviruses: recent genetic and structural insights. Nat. Rev. Microbiol. 12, 673\u2013685 (2014). https:\/\/doi.org\/10.1038\/nrmicro3332","journal-title":"Nat. Rev. Microbiol."},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4142\/jvs.2018.19.2.200","volume":"19","author":"Y Li","year":"2018","unstructured":"Li, Y., et al.: Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method. J. Vet. Sci. 19, 200\u2013206 (2018). https:\/\/doi.org\/10.4142\/jvs.2018.19.2.200","journal-title":"J. Vet. Sci."},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1080\/21645515.2019.1627820","volume":"15","author":"J Ma","year":"2019","unstructured":"Ma, J., et al.: In vitro and in vivo efficacy of a Rift Valley fever virus vaccine based on pseudovirus. Hum. Vaccin. Immunother. 15, 2286\u20132294 (2019). https:\/\/doi.org\/10.1080\/21645515.2019.1627820","journal-title":"Hum. Vaccin. Immunother."},{"key":"13_CR16","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3389\/fmicb.2020.02020","volume":"11","author":"SA Almahboub","year":"2020","unstructured":"Almahboub, S.A., Algaissi, A., Alfaleh, M.A., ElAssouli, M.Z., Hashem, A.M.: Evaluation of neutralizing antibodies against highly pathogenic Coronaviruses: a detailed protocol for a rapid evaluation of neutralizing antibodies using vesicular stomatitis virus Pseudovirus-based assay. Front. Microbiol. 11, 2020 (2020). https:\/\/doi.org\/10.3389\/fmicb.2020.02020","journal-title":"Front. Microbiol."},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"12622","DOI":"10.1128\/JVI.00841-11","volume":"85","author":"J Kortekaas","year":"2011","unstructured":"Kortekaas, J., et al.: Creation of a nonspreading Rift Valley fever virus. J. Virol. 85, 12622\u201312630 (2011). https:\/\/doi.org\/10.1128\/JVI.00841-11","journal-title":"J. Virol."},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2217\/fmb.13.156","volume":"9","author":"B King","year":"2014","unstructured":"King, B., Daly, J.: Pseudotypes: your flexible friends. Future Microbiol. 9, 135\u2013137 (2014). https:\/\/doi.org\/10.2217\/fmb.13.156","journal-title":"Future Microbiol."},{"key":"13_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.vetmic.2016.09.009","volume":"195","author":"Y Lang","year":"2016","unstructured":"Lang, Y., et al.: Mouse model for the Rift Valley fever virus MP12 strain infection. Vet. Microbiol. 195, 70\u201377 (2016). https:\/\/doi.org\/10.1016\/j.vetmic.2016.09.009","journal-title":"Vet. Microbiol."},{"key":"13_CR20","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1016\/j.vaccine.2010.02.018","volume":"28","author":"G Lorenzo","year":"2010","unstructured":"Lorenzo, G., Martin-Folgar, R., Hevia, E., Boshra, H., Brun, A.: Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-\/-) mice induced by different DNA vaccination regimens. Vaccine. 28, 2937\u20132944 (2010). https:\/\/doi.org\/10.1016\/j.vaccine.2010.02.018","journal-title":"Vaccine"},{"key":"13_CR21","doi-asserted-by":"publisher","unstructured":"Wonderlich, E.R., et al.: Peripheral blood biomarkers of disease outcome in a monkey model of Rift Valley fever encephalitis. J. Virol. 92 (2018). https:\/\/doi.org\/10.1128\/JVI.01662-17","DOI":"10.1128\/JVI.01662-17"},{"key":"13_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006474","volume":"12","author":"DR Smith","year":"2018","unstructured":"Smith, D.R., et al.: Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates. PLoS Negl. Trop. Dis. 12, e0006474 (2018). https:\/\/doi.org\/10.1371\/journal.pntd.0006474","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.virol.2010.08.016","volume":"407","author":"DR Smith","year":"2010","unstructured":"Smith, D.R., et al.: The pathogenesis of Rift Valley fever virus in the mouse model. Virology. 407, 256\u2013267 (2010). https:\/\/doi.org\/10.1016\/j.virol.2010.08.016","journal-title":"Virology"},{"key":"13_CR24","doi-asserted-by":"publisher","first-page":"13767","DOI":"10.1128\/JVI.01364-12","volume":"86","author":"SM de Boer","year":"2012","unstructured":"de Boer, S.M., et al.: Heparan sulfate facilitates Rift Valley fever virus entry into the cell. J. Virol. 86, 13767\u201313771 (2012). https:\/\/doi.org\/10.1128\/JVI.01364-12","journal-title":"J. Virol."},{"key":"13_CR25","doi-asserted-by":"publisher","first-page":"13642","DOI":"10.1128\/JVI.01973-12","volume":"86","author":"SM de Boer","year":"2012","unstructured":"de Boer, S.M., et al.: Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein. J. Virol. 86, 13642\u201313652 (2012). https:\/\/doi.org\/10.1128\/JVI.01973-12","journal-title":"J. Virol."},{"key":"13_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s13205-020-2076-y","volume":"10","author":"AF El-Sissi","year":"2020","unstructured":"El-Sissi, A.F., Mohamed, F.H., Danial, N.M., Gaballah, A.Q., Ali, K.A.: Chitosan and chitosan nanoparticles as adjuvant in local Rift Valley fever inactivated vaccine. 3 Biotech. 10, 88 (2020). https:\/\/doi.org\/10.1007\/s13205-020-2076-y","journal-title":"3 Biotech."},{"key":"13_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/vbz.2009.0246","volume":"10","author":"S Moutailler","year":"2010","unstructured":"Moutailler, S., Krida, G., Madec, Y., Bouloy, M., Failloux, A.B.: Replication of Clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, in Aedes and Culex mosquitoes. Vector Borne Zoonotic Dis. 10, 681\u2013688 (2010). https:\/\/doi.org\/10.1089\/vbz.2009.0246","journal-title":"Vector Borne Zoonotic Dis."},{"key":"13_CR28","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","volume":"28","author":"B Dungu","year":"2010","unstructured":"Dungu, B., et al.: Evaluation of the efficacy and safety of the Rift Valley fever Clone 13 vaccine in sheep. Vaccine. 28, 4581\u20134587 (2010). https:\/\/doi.org\/10.1016\/j.vaccine.2010.04.085","journal-title":"Vaccine"},{"key":"13_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/14760584.2017.1321482","volume":"16","author":"T Ikegami","year":"2017","unstructured":"Ikegami, T.: Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate. Expert Rev. Vaccines. 16, 601\u2013611 (2017). https:\/\/doi.org\/10.1080\/14760584.2017.1321482","journal-title":"Expert Rev. Vaccines"},{"key":"13_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002309","volume":"7","author":"E Lopez-Gil","year":"2013","unstructured":"Lopez-Gil, E., et al.: A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection. PLoS Negl. Trop. Dis. 7, e2309 (2013). https:\/\/doi.org\/10.1371\/journal.pntd.0002309","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/1743-422X-10-349","volume":"10","author":"GM Warimwe","year":"2013","unstructured":"Warimwe, G.M., et al.: Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice. Virol. J. 10, 349 (2013). https:\/\/doi.org\/10.1186\/1743-422X-10-349","journal-title":"Virol. J."},{"key":"13_CR32","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1080\/14712598.2019.1662784","volume":"19","author":"T Ikegami","year":"2019","unstructured":"Ikegami, T.: Candidate vaccines for human Rift Valley fever. Expert. Opin. Biol. Ther. 19, 1333\u20131342 (2019). https:\/\/doi.org\/10.1080\/14712598.2019.1662784","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"Suppl 4","key":"13_CR33","doi-asserted-by":"publisher","first-page":"D69","DOI":"10.1016\/j.vaccine.2009.07.046","volume":"27","author":"T Ikegami","year":"2009","unstructured":"Ikegami, T., Makino, S.: Rift valley fever vaccines. Vaccine. 27(Suppl 4), D69\u2013D72 (2009). https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.046","journal-title":"Vaccine"},{"key":"13_CR34","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","volume":"24","author":"K Spik","year":"2006","unstructured":"Spik, K., et al.: Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus. Vaccine. 24, 4657\u20134666 (2006). https:\/\/doi.org\/10.1016\/j.vaccine.2005.08.034","journal-title":"Vaccine"},{"key":"13_CR35","doi-asserted-by":"publisher","first-page":"W452","DOI":"10.1093\/nar\/gks539","volume":"40","author":"NL Sim","year":"2012","unstructured":"Sim, N.L., et al.: SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 40, W452\u2013W457 (2012). https:\/\/doi.org\/10.1093\/nar\/gks539","journal-title":"Nucleic Acids Res."},{"key":"13_CR36","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng, P.C., Henikoff, S.: SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812\u20133814 (2003). https:\/\/doi.org\/10.1093\/nar\/gkg509","journal-title":"Nucleic Acids Res."},{"key":"13_CR37","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar, P., Henikoff, S., Ng, P.C.: Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073\u20131081 (2009). https:\/\/doi.org\/10.1038\/nprot.2009.86","journal-title":"Nat. Protoc."},{"key":"13_CR38","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","volume":"31","author":"Y Choi","year":"2015","unstructured":"Choi, Y., Chan, A.P.: PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 31, 2745\u20132747 (2015). https:\/\/doi.org\/10.1093\/bioinformatics\/btv195","journal-title":"Bioinformatics"},{"key":"13_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12866-021-02107-3","volume":"21","author":"T Gao","year":"2021","unstructured":"Gao, T., et al.: Identification and functional analysis of the SARS-COV-2 nucleocapsid protein. BMC Microbiol. 21, 58 (2021). https:\/\/doi.org\/10.1186\/s12866-021-02107-3","journal-title":"BMC Microbiol."},{"key":"13_CR40","doi-asserted-by":"publisher","unstructured":"Sandell, L., Sharp, N.P.: Fitness effects of mutations: an assessment of PROVEAN predictions using mutation accumulation data. Genome Biol. Evol. 14 (2022). https:\/\/doi.org\/10.1093\/gbe\/evac004","DOI":"10.1093\/gbe\/evac004"}],"container-title":["Advances in Experimental Medicine and Biology","Pseudotyped Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-99-0113-5_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:25:27Z","timestamp":1678879527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-99-0113-5_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9789819901128","9789819901135"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-981-99-0113-5_13","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"16 March 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}